Ayyildiz, A. et al. 2023. Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells. Experimental Oncology. 43, 2 (May 2023), 125–134. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16096.